Skip to main content

A phase II trial of lapatinib in hormone refractory prostate cancer

Publication ,  Journal Article
Whang, YE; Moore, CN; Armstrong, AJ; Rathmell, WK; Godley, PA; Crane, JM; Grigson, GI; Morris, K; Watkins, CP; George, DJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2008

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

May 20, 2008

Volume

26

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Whang, Y. E., Moore, C. N., Armstrong, A. J., Rathmell, W. K., Godley, P. A., Crane, J. M., … George, D. J. (2008). A phase II trial of lapatinib in hormone refractory prostate cancer. JOURNAL OF CLINICAL ONCOLOGY, 26(15).
Whang, Y. E., C. N. Moore, A. J. Armstrong, W. K. Rathmell, P. A. Godley, J. M. Crane, G. I. Grigson, K. Morris, C. P. Watkins, and D. J. George. “A phase II trial of lapatinib in hormone refractory prostate cancer.” JOURNAL OF CLINICAL ONCOLOGY 26, no. 15 (May 20, 2008).
Whang YE, Moore CN, Armstrong AJ, Rathmell WK, Godley PA, Crane JM, et al. A phase II trial of lapatinib in hormone refractory prostate cancer. JOURNAL OF CLINICAL ONCOLOGY. 2008 May 20;26(15).
Whang, Y. E., et al. “A phase II trial of lapatinib in hormone refractory prostate cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 26, no. 15, AMER SOC CLINICAL ONCOLOGY, May 2008.
Whang YE, Moore CN, Armstrong AJ, Rathmell WK, Godley PA, Crane JM, Grigson GI, Morris K, Watkins CP, George DJ. A phase II trial of lapatinib in hormone refractory prostate cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2008 May 20;26(15).

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

May 20, 2008

Volume

26

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences